Ionis reports second quarter financial results and recent business achievements
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Ionis Pharmaceuticals (IONS) Misses Q2 EPS by 13c
August 9, 2022 7:21 AM EDTIonis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.74), $0.13 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $134 million versus the consensus estimate of $140.73 million.
For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.
... More